Scale -


  • Revenue is 4388 Rs Cr; Continuous Growth over 3 years
  • Ebitda is 608 Rs Cr; Continuous Growth over 3 years
  • PBT is 141 Rs Cr; Continuous Growth over 3 years; 5 Year CAGR is -15 %
  • PAT is 278 Rs Cr; Continuous Growth over 3 years; 5 Year CAGR is -13 %
  • Quarterly Revenue is 1289 Rs Cr; Continuous Growth over 3 Quarters

Profitability -


  • PBDIT Margin is 13.84 %; Continuous Growth over 3 years
  • PAT Margin is 6.33 %; Continuous Growth over 3 years; 5 Year CAGR is -10 %
  • Quarterly Ebitda Margin is 15 %; Continuous Growth over 3 Quarters; in Bottom Quartile
  • Quarterly Profit margin is 8 %; Continuous Growth over 3 Quarters

Return -


  • ROCE is 11.1 %; Continuous Growth over 3 years; 5 Year CAGR is -20 %
  • ROA is 5.06 %; Continuous Growth over 3 years; 5 Year CAGR is -20 %
  • ROE is 8.88 %; Continuous Growth over 3 years; 5 Year CAGR is -18 %
  • Asset Turnover is 83 %; Continuous Decline over 3 years

Efficiency -


  • Inventory Turnover Ratio is 4.81; Continuous Growth over 3 years; in Bottom Quartile
  • Operating cash flow is 524 Rs Cr; Continuous Growth over 3 years
  • Current Ratio is 1.29; Continuous Decline over 3 years

Solvancy -


  • Debt/Equity is 0.25; Continuous Decline over 3 years; 5 Year CAGR is 29 %
  • Long term Debt is 322 Rs Cr; Continuous Decline over 3 years; 5 Year CAGR is 34 %
  • Contingent Liabilities is 732 Rs Cr; Annual Growth is 38 %; in Top Quartile
  • Total Debt is 781 Rs Cr; Continuous Growth over 3 years; 5 Year CAGR is 36 %

Quality -


  • Current Tax/PAT is 30 %; Continuous Decline over 3 years
  • Other Expenses/Total Expenses is 27 %; Continuous Decline over 3 years; in Top Quartile
  • Operating cashflow/ebitda is 86 %; in Top Quartile; Continuous Decline over 3 years
  • Operating cashflow/PAT is 189 %; in Top Quartile; 5 Year CAGR is 19 %; Continuous Decline over 3 years
  • Exceptional Items/PBT is -4 %; in Bottom Quartile
  • Change in Inventories/Total Expenses is 1 %; Annual Growth is 21757 %; in Top Quartile

Quarterly Results- overall

Annual Results- Scale

Annual Results- Liquidity

Annual Results- Profitability/Return

Annual Results- Valuation

External Ecosystem


Sector
Major Subsidiaries/Associates
Key Clients

Products


Products
Product details

Operations


Capacity/ Production
Key Facilities
Key Certifications
Raw materials
Recent News
Earnings Beat: Here's What Jubilant Ingrevia Limited (NSE:JUBLINGREA) Analysts Are Forecasting For This Year
Buy Jubilant Ingrevia; target of Rs 900: Anand Rathi
Hold Jubilant Ingrevia; target of Rs 649: Prabhudas Lilladher
Earnings call transcript: Jubilant Ingrevia posts strong Q2 2027 growth
Jubilant Ingrevia Limited Reports Earnings Results for the Second Quarter and Six Months Ended September 30, 2026
Jubilant Ingrevia Q2 FY27 slides: EBITDA surges 51% YoY By Investing.com
Jubilant Ingrevia Q2 net profit surges 60% to ?111 cr
Jubilant Ingrevia Q2 results: Net profit jumps 60% to ?111.4 crore, revenue up 24% to ?1,394 crore, EBITDA margin widens to 15.2%
Jubilant Ingrevia Q2 results: Stock gains as much as 8% after Nutrition & Health Solutions aid earnings growth
Jubilant Ingrevia Q2FY27 Results: Net profit up 60% YoY to ?111.4 crore
Jubilant Ingrevia Records Strong Q2 FY27: Revenue At ?1,394 Crore, PAT Surges 61%, ZettaOne Stake Acquired
Jubilant Ingrevia reports ?1,394 crore revenue in Q2 FY27
Jubilant Ingrevia reports ?189.2 crore acquisition in robust Q2 FY27 results
Jubilant Ingrevia Reports Q2 Financial Results Against ?694.7 Million Prior-Year Base
Jubilant Ingrevia: Board Approves Q2 FY27 Unaudited Financial Results
Jubilant Ingrevia forms new arm to complete Zettaone Technologies acquisition